Article Details

CTI BioPharma (NASDAQ:CTIC) Rating Increased to Buy at ValuEngine

Retrieved on: 2020-01-05 12:07:30

Tags for this article:

Click the tags to see associated articles and topics

CTI BioPharma (NASDAQ:CTIC) Rating Increased to Buy at ValuEngine. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC lifted its holdings in CTI BioPharma by 24.5% during the second quarter. <b>Renaissance Technologies</b> LLC now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up